LU80470A1 - "noveaux derives de 4-animo-2-(piperazin-1-yl ou homopipe-razin-1-yl)-quinazoline, leur procede de production et composition pharmaceutique les contenant. - Google Patents

"noveaux derives de 4-animo-2-(piperazin-1-yl ou homopipe-razin-1-yl)-quinazoline, leur procede de production et composition pharmaceutique les contenant. Download PDF

Info

Publication number
LU80470A1
LU80470A1 LU80470A LU80470A LU80470A1 LU 80470 A1 LU80470 A1 LU 80470A1 LU 80470 A LU80470 A LU 80470A LU 80470 A LU80470 A LU 80470A LU 80470 A1 LU80470 A1 LU 80470A1
Authority
LU
Luxembourg
Prior art keywords
group
formula
compound
acid
mixture
Prior art date
Application number
LU80470A
Other languages
English (en)
French (fr)
Inventor
S Campbell
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of LU80470A1 publication Critical patent/LU80470A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
LU80470A 1977-11-05 1978-11-03 "noveaux derives de 4-animo-2-(piperazin-1-yl ou homopipe-razin-1-yl)-quinazoline, leur procede de production et composition pharmaceutique les contenant. LU80470A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB4612877 1977-11-05
GB4612877 1977-11-05

Publications (1)

Publication Number Publication Date
LU80470A1 true LU80470A1 (fr) 1980-06-05

Family

ID=10439957

Family Applications (2)

Application Number Title Priority Date Filing Date
LU80470A LU80470A1 (fr) 1977-11-05 1978-11-03 "noveaux derives de 4-animo-2-(piperazin-1-yl ou homopipe-razin-1-yl)-quinazoline, leur procede de production et composition pharmaceutique les contenant.
LU88331C LU88331I2 (fr) 1977-11-05 1993-06-24 Doxazosin (Cardura)

Family Applications After (1)

Application Number Title Priority Date Filing Date
LU88331C LU88331I2 (fr) 1977-11-05 1993-06-24 Doxazosin (Cardura)

Country Status (36)

Country Link
JP (1) JPS5498792A (fi)
AR (2) AR219562A1 (fi)
AT (1) AT365186B (fi)
AU (1) AU509329B2 (fi)
BE (1) BE871771A (fi)
CA (1) CA1088059A (fi)
CH (1) CH643255A5 (fi)
CS (2) CS207671B2 (fi)
DD (1) DD139850A5 (fi)
DE (1) DE2847623C2 (fi)
DK (1) DK154082C (fi)
EG (1) EG13594A (fi)
ES (2) ES474805A1 (fi)
FI (1) FI64366C (fi)
FR (1) FR2407929A1 (fi)
GR (1) GR81514B (fi)
HK (1) HK94284A (fi)
HU (1) HU176306B (fi)
IE (1) IE47888B1 (fi)
IL (1) IL55857A (fi)
IN (1) IN148828B (fi)
IT (1) IT1100919B (fi)
KE (1) KE3350A (fi)
LU (2) LU80470A1 (fi)
MY (1) MY8500286A (fi)
NL (2) NL174549C (fi)
NO (1) NO150158C (fi)
NZ (1) NZ188813A (fi)
PH (1) PH13966A (fi)
PL (2) PL119419B1 (fi)
PT (1) PT68735A (fi)
SE (1) SE437518B (fi)
SU (1) SU816403A3 (fi)
UA (1) UA8324A1 (fi)
YU (2) YU40204B (fi)
ZA (1) ZA786184B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986002644A1 (en) * 1984-11-01 1986-05-09 Takeda Chemical Industries, Ltd. 1,5-benzoxathiepin derivatives and process for their preparation
WO1985002617A1 (en) * 1983-12-14 1985-06-20 Takeda Chemical Industries. Ltd. 1,5-benzoxathiepin derivatives and process for their preparation
WO1985004658A1 (en) * 1984-04-04 1985-10-24 Takeda Chemical Industries, Ltd. 1,5-benzoxathiepine derivatives and their preparation
EP0849264A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von doxazosinmesylat (Form I)
EP0849265A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von Doxazosin-Mesylat (Form II)
ES2282997T3 (es) * 1996-12-20 2007-10-16 Heumann Pcs Gmbh Nueva forma polimorfa de mesilato e doxazosina (forma iii).
TW448155B (en) * 1999-03-29 2001-08-01 Dev Center Biotechnology Method for producing amide compounds and quinazolin derivatives
EP1403263B1 (en) * 2002-09-27 2005-06-22 Council of Scientific and Industrial Research Process for the preparation of N-(2,3-dihydrobenzo 1,4 dioxin-2-carbonyl) piperazine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3635979A (en) * 1969-09-29 1972-01-18 Pfizer Certain 6- and/or 7-alkoxy-substituted-2 4-bis(disubstituted amino) quinazolines
US3669968A (en) * 1970-05-21 1972-06-13 Pfizer Trialkoxy quinazolines

Also Published As

Publication number Publication date
CA1088059A (en) 1980-10-21
GR81514B (fi) 1984-12-11
FR2407929A1 (fr) 1979-06-01
NL930062I2 (nl) 1993-11-16
NL7810909A (nl) 1979-05-08
CS354491A3 (en) 1992-06-17
NL174549C (nl) 1984-07-02
ZA786184B (en) 1979-10-31
YU40204B (en) 1985-08-31
DK428678A (da) 1979-05-06
MY8500286A (en) 1985-12-31
HK94284A (en) 1984-12-07
CS207671B2 (en) 1981-08-31
ES474805A1 (es) 1980-01-16
CH643255A5 (en) 1984-05-30
FI783347A (fi) 1979-05-06
PH13966A (en) 1980-11-12
SE437518B (sv) 1985-03-04
EG13594A (en) 1982-03-31
YU38683A (en) 1983-06-30
AR223015A1 (es) 1981-07-15
SU816403A3 (ru) 1981-03-23
IL55857A0 (en) 1979-01-31
DD139850A5 (de) 1980-01-23
NL930062I1 (nl) 1993-09-01
DK154082B (da) 1988-10-10
ATA784378A (de) 1981-05-15
YU255378A (en) 1983-06-30
LU88331I2 (fr) 1994-05-04
KE3350A (en) 1983-12-16
AR219562A1 (es) 1980-08-29
NO150158C (no) 1984-08-29
NL174549B (nl) 1984-02-01
NO150158B (no) 1984-05-21
IE782179L (en) 1979-05-05
IT1100919B (it) 1985-09-28
HU176306B (en) 1981-01-28
PL119419B1 (en) 1981-12-31
IN148828B (fi) 1981-06-27
NO783705L (no) 1979-05-08
ES8308559A1 (es) 1980-07-16
UA8324A1 (uk) 1996-03-29
DE2847623C2 (de) 1983-06-01
IT7829434A0 (it) 1978-11-03
AU4132278A (en) 1979-05-17
YU40419B (en) 1985-12-31
AT365186B (de) 1981-12-28
PL119586B1 (en) 1982-01-30
NZ188813A (en) 1980-10-08
ES480121A0 (es) 1980-07-16
FI64366B (fi) 1983-07-29
SE7811382L (sv) 1979-05-06
FI64366C (fi) 1983-11-10
PT68735A (en) 1978-12-01
JPS5625233B2 (fi) 1981-06-11
DK154082C (da) 1989-02-27
IE47888B1 (en) 1984-07-11
DE2847623A1 (de) 1979-05-23
JPS5498792A (en) 1979-08-03
BE871771A (fr) 1979-05-03
PL210681A1 (fi) 1979-11-05
IL55857A (en) 1982-07-30
AU509329B2 (en) 1980-05-08
FR2407929B1 (fi) 1981-02-27

Similar Documents

Publication Publication Date Title
EP0307303B1 (fr) [(Pyrimidinyl-2)-aminoalkyl]-1 pipéridines, leur préparation et leur application en thérapeutique
FR2689888A1 (fr) Nouveaux dérivés de pérhydroisoindole, leur préparation et les compositions pharmaceutiques qui les contiennent.
EP0354094B1 (fr) Dérivés d'indolone, leur préparation et leur application en thérapeutique
FR2561244A1 (fr) Composes heterocycliques du type tetrahydrocarbazolone, procede pour leur preparation et composition pharmaceutique les comprenant
CA2104883A1 (fr) Derives d'acide thienyl ou pyrrolyl carboxyliques, leur preparation et medicaments les contenant
EP0338939B1 (fr) Dérivé de l'histamine, sa préparation et son application en thérapeutique
EP0049555A1 (fr) Nouveaux dérivés de l'acide 2-trifluorométhyl-4-hydroxy-3-quinoline carboxylique et leur procédé de préparation
FR2637591A1 (fr) Derives de quinoleinone, leur preparation et leur application en therapeutique
EP1828125B1 (fr) Derives d'arylpiperazine et leur utilisation comme ligands selectifs du recepteur d3 de la dopamine
LU80470A1 (fr) "noveaux derives de 4-animo-2-(piperazin-1-yl ou homopipe-razin-1-yl)-quinazoline, leur procede de production et composition pharmaceutique les contenant.
CA2055326A1 (fr) Derives de la n-benzoyl proline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA1095047A (fr) Procede de preparation de nouveaux derives du 1,4- benzodioxane
US7776852B2 (en) Process for producing highly pure midazolam and salts thereof
JPH0150698B2 (fi)
EP0524846A1 (fr) Dérivés de 2-(pipéridin-1-y1) éthanol, leur préparation et leur application en thérapeutique
EP0147312B1 (fr) Nouvelles imidazo /1,2-c/ pyrimidines et leurs sels, leur procédé de préparation, leur application à titre de médicaments et les compositions les renfermant
DD249271A5 (de) Verfahren zur herstellung von 9-chlor-1,5-benzothiazepin-derivaten
EP0635002B1 (fr) Nouveaux derives de perhydroisoindole, et leur preparation
CA2557942A1 (fr) Derives de carbamate de 2h- ou 3h-benzo[e]indazol-1-yle, leur preparation et leur application en therapeutique
EP0402232A1 (fr) Dérivés de pyridobenzoindole, leur préparation et les compositions qui les contiennent
EP1492792B1 (fr) Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino¬4,5-b|indole-1-acetamide,leur preparation et leur application en therapeutique
AP899A (en) Indole derivatives useful in therapy.
EP0302787B1 (fr) Dérivés de (pipéridinyl-4)méthyl-2 benzofuro[2,3-c]pyridines, leur préparation et leur application en thérapeutique
FR2697251A1 (fr) N-oxydes de dérivés de 1-(4-chlorophényl)-2-[4-[(4-fluorophényl)méthyl] pipéridin-1-yl]éthanol, leur procédé de préparation et leur application en thérapeutique.
WO2012168664A1 (fr) 4-{3-[trans-hexahydrocyclopenta[c]pyrrol-2(1h)-yl] propoxy}benzamide, son procede de preparation et les compositions pharmaceutiques qui le contiennent